The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2024

Filed:

Dec. 27, 2019
Applicant:

Gambro Lundia Ab, Lund, SE;

Inventors:

Paolo Rovatti, Modena, IT;

Alessandro Surace, Modena, IT;

Carlo Alberto Lodi, Modena, IT;

Assignee:

Gambro Lundia AB, Lund, SE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/16 (2006.01); A61M 1/34 (2006.01); A61M 1/36 (2006.01); A61M 60/113 (2021.01); A61M 60/279 (2021.01); A61M 60/37 (2021.01); G16H 10/40 (2018.01); G16H 20/40 (2018.01);
U.S. Cl.
CPC ...
A61M 1/1607 (2014.02); A61M 1/1609 (2014.02); A61M 1/1613 (2014.02); A61M 1/1656 (2013.01); A61M 1/3413 (2013.01); A61M 1/3417 (2014.02); A61M 1/3661 (2014.02); A61M 60/113 (2021.01); A61M 60/279 (2021.01); A61M 60/37 (2021.01); G16H 10/40 (2018.01); G16H 20/40 (2018.01); A61M 2205/3317 (2013.01); A61M 2205/3334 (2013.01); A61M 2230/20 (2013.01);
Abstract

An extracorporeal blood treatment apparatus is provided comprising a filtration unit connected to a blood circuit and to a dialysate circuit, a preparation device for preparing and regulating the composition of the dialysis fluid; a control unit is configured for setting a sodium concentration value for the dialysis fluid in the dialysis supply line at a set point based on the physician prescription; starting from the initial patient plasma conductivity, estimated at the beginning of the treatment, and based on the target plasma conductivity/sodium concentration which is equivalent to the dialysate conductivity/sodium concentration prescribed, the control unit determines the minimum constant gradient between dialysis fluid and plasma conductivity/concentration to be maintained during treatment to achieve the conductivity/concentration target in the patient plasma at the end of the session.


Find Patent Forward Citations

Loading…